¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31
±³À°ÀÏÀÚ : 2024-05-31
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø ¿¬±¸°ü

±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸

´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í ºñȸ¿ø 50,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 13:30~14:00 Clinical significance of BRAFV600E-positive cells as measurable residual disease (MRD) in Langerhans cell histiocytosi Ko Kudo(Hirosaki University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 14:00~14:30 How we treat LCH(Langerhans cell histiocytosis) in Taiwan Grace Yu Mei Liao(Medical University, Taiwan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 14:30~15:00 Unraveling the Genetic Tapestry of Langerhans Cell Histiocytosis in Korean Patients °í°æ³²(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 15:15~15:45 Stratified treatment of pediatric HLH(Hemophagocytic lymphohistiocytosis) Rui Zhang(Capital  Medical University, China)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 15:45~16:15 Primary and secondary hemophagocytic lymphohistiocytosis in Japan Shouichi Ohga(Kyushu University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 16:15~16:45 HLH(Hemophagocytic lymphohistiocytosis) in Korea ÃÖÁ¤À±(¼­¿ïÀÇ´ë )

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 17:00~17:30 CAR-T related CSS & cytopenia Yoshiyuki Takahashi(Nagoya University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 17:30~18:00 CAR-T related HLH(Hemophagocytic lymphohistiocytosis) À¯Àç¿ø(°¡Å縯ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀ忬±¸ÇÐȸ ºÎ¿ï°æÁöȸ Á¤±âÁý´ãȸ : 2024-04-29
´ÙÀ½±Û ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
795 ´ë±¸ ôÃß°üÀý ÀçÈ° Ä¡·áÀÇ ÃÖ½ÅÁö°ß ½ÉÆ÷Áö¿ò : 2018-09-29 0 367 2018-09-06
794 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ The 23rd Seoul International Symposium : 2018-09-29 0 1,126 2018-09-06
793 ¼­¿ï Á¦104Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ : 2018-09-29 0 373 2018-09-06
792 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø ´ëÇѽɺÎÀüÇÐȸ Á¦2ȸ °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-28 0 408 2018-09-06
791 °æºÏ ´ëÇѺ´¸®ÇÐȸ ´ë±¸°æºÏÁöȸ ÇмúÁý´ãȸ : 2018-09-28 0 268 2018-09-06
790 ºÎ»ê ´ëÇÑÇǺΰúÇÐȸ ºÎ»ê¿ï»ê°æ³² ÁöºÎȸ : 2018-09-28 0 594 2018-09-06
789 ¼­¿ï Á¦104Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ : 2018-09-28 0 1,319 2018-09-06
788 °­¿ø ÇѸ²´ëÇб³Ãáõ¼º½Éº´¿ø Áö¿ªÀǾàÇ°¾ÈÀü¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-09-21 0 605 2018-09-06
787 °­¿ø ´ë»óÆ÷Áø Ä¡·á ¹× °ñ´Ù°øÁõ Ä¡·á¿¡ ´ëÇÑ ÃֽŠÁö°ß : 2018-09-20 0 813 2018-09-06
786 ¿ï»ê ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Á¤½ÅÁúȯ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-09-20 0 463 2018-09-06
785 ¼­¿ï 2018³â ¼­¿ïƯº°½Ã ½ÅÁ¾¡¤ÀçÃâÇö °¨¿°º´ À§±â°ü¸® ´ëÀÀÈÆ·Ã : 2018-09-20 0 366 2018-09-06
784 ´ë±¸ °è¸í´ëÇб³ µ¿»êº´¿ø ´ëÇÑÅëÁõÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-09-20 0 607 2018-09-06
783 ºÎ»ê ºÎ»ê´ëÇб³º´¿ø ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ºÎ¿ï°æÁöȸ 9¿ù ¿¬¼ö°­Á : 2018-09-20 0 629 2018-09-06
782 °æ±â Àû±ØÀû Ç÷¾Ð Á¶ÀýÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ±Ù°Å±â¹Ý Á¢±Ù¹ý : 2018-09-20 0 370 2018-09-06
781 ´ë±¸ ´ë±¸ÆÄƼ¸¶º´¿ø ´ëÇÑÀçÈ°ÀÇÇÐȸ 97Â÷ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-09-20 0 911 2018-09-06
1351 | 1352 | 1353 | 1354 | 1355 | 1356 | 1357 | 1358 | 1359 | 1360
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷